| Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis MK Ruhland, AJ Loza, AH Capietto, X Luo, BL Knolhoff, KC Flanagan, ... Nature communications 7 (1), 11762, 2016 | 365 | 2016 |
| TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy M Molgora, E Esaulova, W Vermi, J Hou, Y Chen, J Luo, S Brioschi, ... Cell 182 (4), 886-900. e17, 2020 | 354 | 2020 |
| Vav3 regulates osteoclast function and bone mass R Faccio, SL Teitelbaum, K Fujikawa, J Chappel, A Zallone, ... Nature medicine 11 (3), 284-290, 2005 | 323 | 2005 |
| Oxytocin is an anabolic bone hormone R Tamma, G Colaianni, L Zhu, A DiBenedetto, G Greco, G Montemurro, ... Proceedings of the National Academy of Sciences 106 (17), 7149-7154, 2009 | 281 | 2009 |
| Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells K Fujikawa, AV Miletic, FW Alt, R Faccio, T Brown, J Hoog, J Fredericks, ... The Journal of experimental medicine 198 (10), 1595-1608, 2003 | 279 | 2003 |
| c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation R Faccio, S Takeshita, A Zallone, FP Ross, SL Teitelbaum The Journal of clinical investigation 111 (5), 749-758, 2003 | 256 | 2003 |
| PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2 D Mao, H Epple, B Uthgenannt, DV Novack, R Faccio The Journal of clinical investigation 116 (11), 2869-2879, 2006 | 247 | 2006 |
| Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin R Faccio, DV Novack, A Zallone, FP Ross, SL Teitelbaum The Journal of cell biology 162 (3), 499-509, 2003 | 218 | 2003 |
| TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis K Otero, M Shinohara, H Zhao, M Cella, S Gilfillan, A Colucci, R Faccio, ... The Journal of Immunology 188 (6), 2612-2621, 2012 | 195 | 2012 |
| Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, ... Nature communications 9 (1), 1250, 2018 | 191 | 2018 |
| The interplay between the bone and the immune system G Mori, P D'Amelio, R Faccio, G Brunetti Journal of Immunology Research 2013, 2013 | 189 | 2013 |
| RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice S Vaira, M Alhawagri, I Anwisye, H Kitaura, R Faccio, DV Novack The Journal of clinical investigation 118 (6), 2088-2097, 2008 | 188 | 2008 |
| RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation S Vaira, T Johnson, AC Hirbe, M Alhawagri, I Anwisye, B Sammut, ... Proceedings of the National Academy of Sciences 105 (10), 3897-3902, 2008 | 187 | 2008 |
| T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction S Colucci, G Brunetti, R Rizzi, A Zonno, G Mori, G Colaianni, D Del Prete, ... Blood 104 (12), 3722-3730, 2004 | 173 | 2004 |
| A Glanzmann’s mutation in β3 integrin specifically impairs osteoclast function X Feng, DV Novack, R Faccio, DS Ory, K Aya, MI Boyer, KP McHugh, ... The Journal of clinical investigation 107 (9), 1137-1144, 2001 | 173 | 2001 |
| Cortactin has an essential and specific role in osteoclast actin assembly S Tehrani, R Faccio, I Chandrasekar, FP Ross, JA Cooper Molecular biology of the cell 17 (7), 2882-2895, 2006 | 162 | 2006 |
| Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCγ2 signaling axis in mice DB Graham, CM Robertson, J Bautista, F Mascarenhas, MJ Diacovo, ... The Journal of clinical investigation 117 (11), 3445-3452, 2007 | 145 | 2007 |
| Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer L D’Amico, S Mahajan, AH Capietto, Z Yang, A Zamani, B Ricci, ... Journal of Experimental Medicine 213 (5), 827-840, 2016 | 142 | 2016 |
| The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling MWH Wang, S Wei, R Faccio, S Takeshita, P Tebas, WG Powderly, ... The Journal of clinical investigation 114 (2), 206-213, 2004 | 140 | 2004 |
| Osteoclast motility: putting the brakes on bone resorption DV Novack, R Faccio Ageing research reviews 10 (1), 54-61, 2011 | 117 | 2011 |
